A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 Weeks

Clinical trial NCT06851559 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06851559
Sponsor: Phathom Pharmaceuticals, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Eosinophilic Esophagitis

Start date: 2025-10-30
Primary completion: 2026-10-01
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.